- Home
- RLGT vs CADL Comparison
RLGT vs CADL Comparison
Compare RLGT & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLGT
- CADL
- Stock Information
- Founded
- RLGT 2001
- CADL 1999
- Country
- RLGT United States
- CADL United States
- Employees
- RLGT N/A
- CADL N/A
- Industry
- RLGT Oil Refining/Marketing
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- RLGT Consumer Discretionary
- CADL Health Care
- Exchange
- RLGT Nasdaq
- CADL Nasdaq
- Market Cap
- RLGT 295.7M
- CADL 306.4M
- IPO Year
- RLGT N/A
- CADL 2021
- Fundamental
- Price
- RLGT $6.22
- CADL $5.57
- Analyst Decision
- RLGT
- CADL Strong Buy
- Analyst Count
- RLGT 0
- CADL 4
- Target Price
- RLGT N/A
- CADL $21.00
- AVG Volume (30 Days)
- RLGT 167.5K
- CADL 1.0M
- Earning Date
- RLGT 05-08-2025
- CADL 03-13-2025
- Dividend Yield
- RLGT N/A
- CADL N/A
- EPS Growth
- RLGT 32.26
- CADL N/A
- EPS
- RLGT 0.29
- CADL N/A
- Revenue
- RLGT $858,699,000.00
- CADL N/A
- Revenue This Year
- RLGT $12.86
- CADL N/A
- Revenue Next Year
- RLGT $5.75
- CADL N/A
- P/E Ratio
- RLGT $21.19
- CADL N/A
- Revenue Growth
- RLGT N/A
- CADL N/A
- 52 Week Low
- RLGT $4.83
- CADL $1.56
- 52 Week High
- RLGT $7.94
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- RLGT 41.00
- CADL 30.13
- Support Level
- RLGT $6.04
- CADL $7.85
- Resistance Level
- RLGT $6.35
- CADL $8.69
- Average True Range (ATR)
- RLGT 0.16
- CADL 0.62
- MACD
- RLGT 0.01
- CADL -0.33
- Stochastic Oscillator
- RLGT 36.46
- CADL 4.60
About RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.